Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejim.2025.106455 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pathophysiology and treatment of exercise-associated hyponatremia.
J Endocrinol Invest
September 2025
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Exercise associated hyponatremia (EAH) is a medical condition that can occur during physical exertion. Initially, EAH was considered to be restricted to extreme endurance activities, such as ultramarathons and Ironman triathlons. However, it has been more recently recognized in a variety of sports, including team sports and in shorter-duration events.
View Article and Find Full Text PDFExercise Capacity for the Window of Atrial Fibrillation Prevention.
JACC Asia
August 2025
Open Innovation Center, National Cerebral and Cardiovascular Center, Suita, Japan. Electronic address:
Comparison of Short- and Long-Term Cardiovascular Disease Risk Assessment Tools in US Young Adults.
J Am Heart Assoc
September 2025
Department of Research & Evaluation Kaiser Permanente Southern California Pasadena CA USA.
Background: In 2023, the American Heart Association published the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations for estimating atherosclerotic cardiovascular disease (ASCVD) risk in adults aged 30 to 79 years. We compared PREVENT's performance with existing US guideline recommended models-Pooled Cohort Equations for 10-year ASCVD risk and FHS (Framingham Heart Study) equations for 30-year ASCVD risk-among young adults.
Methods: We analyzed adults aged 20 to 39 years without baseline ASCVD from 2 sources: (1) pooled data from 2 large epidemiologic cohorts (CARDIA [Coronary Artery Risk Development in Young Adults] and FHS, n=7763), and (2) electronic health records from Kaiser Permanente Southern California (n=266 378).
Association of heart attack or stroke history with current mental health symptoms among adults in the USA: cross-sectional analyses of nationally representative samples.
BMJ Open
September 2025
Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Objectives: This study uses nationally representative survey data from the USA to estimate the relationship between a history of heart attack or stroke with the prevalence of mental health symptoms.
Design: Cross-sectional.
Setting: Data from the 2019 and the 2018 National Health Interview Survey (NHIS) sample adult interview.
Naoxintong Capsules for Secondary Prevention of Ischemic Stroke: Meta-Analyses of Clinical and Preclinical Evidence.
J Ethnopharmacol
September 2025
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address:
Ethnopharmacological Relevance: Naoxintong, a Chinese patent medicine, may serve as an adjunctive therapy for the secondary prevention of ischemic stroke.
Aim Of The Study: To assess the effectiveness and safety of Naoxintong in preventing recurrent ischemic stroke and to review its preclinical evidence.
Materials And Methods: A search of electronic databases and registries was performed to locate relevant randomized controlled trials (RCTs) on Naoxintong for preventing ischemic stroke recurrence and animal studies exploring its mechanisms in atherosclerosis improvement.